A Phase 1, Open-label, Randomized, PK and Safety Study To Assess Bronchopulmonary Disposition of Intravenous TP-6076 in Healthy Men and Women
Phase of Trial: Phase I
Latest Information Update: 19 Dec 2018
At a glance
- Drugs TP 6076 (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- Acronyms BAL
- Sponsors Tetraphase Pharmaceuticals
- 10 Dec 2018 Status changed from not yet recruiting to recruiting.
- 08 Nov 2018 According to a Tetraphase Pharmaceuticals media release, this study is expected to start in 1Q 2019.
- 08 Nov 2018 Planned initiation date changed from 1 Nov 2018 to 1 Jan 2019, according to a Tetraphase Pharmaceuticals media release.